Understanding the immune response in sarcoidosis and the effects of a specific treatment
Delineation of the immunobiology of sarcoidosis and characterization of the effects of Janus kinase inhibition
This study is looking at how a new type of medicine called JAK inhibitors might help treat sarcoidosis, especially for African Americans who haven't had success with other treatments, by examining skin and blood samples to learn more about the immune system's role in the disease.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10877021 on NIH RePORTER |
What this research studies
This research investigates sarcoidosis, an inflammatory condition that leads to the formation of granulomas in various tissues, particularly affecting African Americans. The study aims to explore how Janus kinase (JAK) inhibitors can be used to treat sarcoidosis, especially in cases where other treatments have failed. By analyzing skin biopsies and blood samples from patients, researchers will create a detailed map of the immune signals involved in granuloma formation. This approach combines advanced techniques like single-cell RNA sequencing to better understand the disease and improve treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with sarcoidosis, particularly those who have not responded well to existing treatments.
Not a fit: Patients with sarcoidosis who are already responding well to current therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for sarcoidosis, improving patient outcomes and quality of life.
How similar studies have performed: Previous research has shown promise in using JAK inhibitors for treating other inflammatory conditions, suggesting potential success in this novel application for sarcoidosis.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Damsky, William — Yale University
- Study coordinator: Damsky, William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.